Exclusive Content

Speaker Interviews

Watch now to learn about our speakers' latest work, key priorities, and insights on the future of the industry.

This banner advertises our new speaker interview with Jeffrey Jones, who is a Chief Medical Officer at Cullinan Therapeutics.

This banner advertises our new speaker interview with Chris Jewell, who is a Chief Scientific Officer at Cartesian Therapeutics.

This banner advertises our new speaker interview with Samik Basu, who is a Chief Scientific Officer at Cabaletta Bio.

Delegate List

Download the current 2024 delegate list to see who you could be joining!

This chart shows the affiliation and job titles in attendance at the cell therapy for autoimmune disease summit.

NEW Data

CAR Therapies for Autoimmune Diseases Cover

Download now to gain valuable insights into market research on CAR therapies for autoimmune diseases.

This graph shows the top 10 cell types / cell therapy assets for autoimmune diseases. Ranking in first, is T-Cells, T Regulatory Cells and Mesenchymal Stem Cells.

This graph shows the cumulative number of new cell therapies being developed for autoimmune diseases. There has been a 25% increase between 2017-2024 (CAGR).

Have a look at our Cell Therapy Info Pack!

Cell Therapy Info Pack, exclusive content for our users.